biote Corp. (NASDAQ: BTMD) Stock Competitors & Peer Comparison
See BTMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BTMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BTMD | $1.08 | -0.46% | 47.2M | 9.73 | $0.11 | N/A |
| HCA | $454.88 | -0.86% | 98.5B | 15.70 | $28.96 | +0.67% |
| THC | $266.39 | -0.32% | 21.4B | 15.45 | $17.24 | N/A |
| EHC | $121.71 | -4.82% | 12B | 20.84 | $5.84 | +0.64% |
| DVA | $187.00 | -0.17% | 11.9B | 14.62 | $12.80 | N/A |
| FMS | $21.94 | -1.04% | 11.7B | 8.24 | $2.66 | +3.94% |
| UHS | $182.29 | -1.52% | 10.7B | 8.09 | $22.54 | +0.44% |
| ENSG | $173.05 | -2.03% | 10.1B | 25.07 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $45.85 | -2.26% | 7.3B | 24.25 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
BTMD vs HCA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, HCA has a market cap of 98.5B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while HCA trades at $454.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas HCA's P/E ratio is 15.70. In terms of profitability, BTMD's ROE is -0.09%, compared to HCA's ROE of -1.13%. Regarding short-term risk, BTMD is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
BTMD vs THC Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, THC has a market cap of 21.4B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while THC trades at $266.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas THC's P/E ratio is 15.45. In terms of profitability, BTMD's ROE is -0.09%, compared to THC's ROE of +0.51%. Regarding short-term risk, BTMD is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
BTMD vs EHC Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, EHC has a market cap of 12B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while EHC trades at $121.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas EHC's P/E ratio is 20.84. In terms of profitability, BTMD's ROE is -0.09%, compared to EHC's ROE of +0.25%. Regarding short-term risk, BTMD is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
BTMD vs DVA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, DVA has a market cap of 11.9B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while DVA trades at $187.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas DVA's P/E ratio is 14.62. In terms of profitability, BTMD's ROE is -0.09%, compared to DVA's ROE of -1.24%. Regarding short-term risk, BTMD is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check DVA's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
BTMD vs FMS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, FMS has a market cap of 11.7B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while FMS trades at $21.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas FMS's P/E ratio is 8.24. In terms of profitability, BTMD's ROE is -0.09%, compared to FMS's ROE of +0.07%. Regarding short-term risk, BTMD is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check FMS's competition here
Universal Health Services, Inc. (NYSE: UHS)
BTMD vs UHS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, UHS has a market cap of 10.7B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while UHS trades at $182.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas UHS's P/E ratio is 8.09. In terms of profitability, BTMD's ROE is -0.09%, compared to UHS's ROE of +0.21%. Regarding short-term risk, BTMD is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
BTMD vs ENSG Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ENSG trades at $173.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ENSG's P/E ratio is 25.07. In terms of profitability, BTMD's ROE is -0.09%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, BTMD is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
BTMD vs OSH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas OSH's P/E ratio is -17.65. In terms of profitability, BTMD's ROE is -0.09%, compared to OSH's ROE of +4.64%. Regarding short-term risk, BTMD is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
BTMD vs PACS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, PACS has a market cap of 7.3B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while PACS trades at $45.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas PACS's P/E ratio is 24.25. In terms of profitability, BTMD's ROE is -0.09%, compared to PACS's ROE of +0.27%. Regarding short-term risk, BTMD is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
BTMD vs CHE Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CHE trades at $508.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CHE's P/E ratio is 23.54. In terms of profitability, BTMD's ROE is -0.09%, compared to CHE's ROE of +0.29%. Regarding short-term risk, BTMD is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
BTMD vs HIMS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, HIMS has a market cap of 6.3B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while HIMS trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas HIMS's P/E ratio is -43.96. In terms of profitability, BTMD's ROE is -0.09%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, BTMD is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
BTMD vs LHCG Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas LHCG's P/E ratio is 82.83. In terms of profitability, BTMD's ROE is -0.09%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, BTMD is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check LHCG's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
BTMD vs CON Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CON has a market cap of 4.9B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CON trades at $38.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CON's P/E ratio is 24.01. In terms of profitability, BTMD's ROE is -0.09%, compared to CON's ROE of +0.47%. Regarding short-term risk, BTMD is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
BTMD vs OPCH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while OPCH trades at $31.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas OPCH's P/E ratio is 18.14. In terms of profitability, BTMD's ROE is -0.09%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, BTMD is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check OPCH's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
BTMD vs LFST Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, LFST has a market cap of 4.5B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while LFST trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas LFST's P/E ratio is 88.65. In terms of profitability, BTMD's ROE is -0.09%, compared to LFST's ROE of +0.03%. Regarding short-term risk, BTMD is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check LFST's competition here
National HealthCare Corporation (AMEX: NHC)
BTMD vs NHC Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, NHC has a market cap of 3.8B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while NHC trades at $239.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas NHC's P/E ratio is 30.55. In terms of profitability, BTMD's ROE is -0.09%, compared to NHC's ROE of +0.13%. Regarding short-term risk, BTMD is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
BTMD vs AMED Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AMED's P/E ratio is 39.30. In terms of profitability, BTMD's ROE is -0.09%, compared to AMED's ROE of +0.04%. Regarding short-term risk, BTMD is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
BTMD vs ACHC Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ACHC has a market cap of 2.8B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ACHC trades at $30.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ACHC's P/E ratio is 15.17. In terms of profitability, BTMD's ROE is -0.09%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, BTMD is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
BTMD vs AVAH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AVAH trades at $12.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AVAH's P/E ratio is 18.29. In terms of profitability, BTMD's ROE is -0.09%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, BTMD is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
BTMD vs GRDN Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, GRDN has a market cap of 2.5B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while GRDN trades at $40.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas GRDN's P/E ratio is 35.19. In terms of profitability, BTMD's ROE is -0.09%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, BTMD is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check GRDN's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
BTMD vs BKD Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, BKD has a market cap of 2.4B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while BKD trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas BKD's P/E ratio is -17.00. In terms of profitability, BTMD's ROE is -0.09%, compared to BKD's ROE of +4.06%. Regarding short-term risk, BTMD is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check BKD's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
BTMD vs MD Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while MD trades at $27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas MD's P/E ratio is 12.19. In terms of profitability, BTMD's ROE is -0.09%, compared to MD's ROE of +0.20%. Regarding short-term risk, BTMD is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
BTMD vs ADUS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ADUS trades at $115.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ADUS's P/E ratio is 17.24. In terms of profitability, BTMD's ROE is -0.09%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, BTMD is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
BTMD vs SEM Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas SEM's P/E ratio is 15.43. In terms of profitability, BTMD's ROE is -0.09%, compared to SEM's ROE of +0.08%. Regarding short-term risk, BTMD is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
BTMD vs SGRY Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while SGRY trades at $14.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas SGRY's P/E ratio is 37.72. In terms of profitability, BTMD's ROE is -0.09%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, BTMD is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check SGRY's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
BTMD vs ASTH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ASTH trades at $36.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ASTH's P/E ratio is 44.46. In terms of profitability, BTMD's ROE is -0.09%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, BTMD is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
BTMD vs AMEH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AMEH's P/E ratio is 39.25. In terms of profitability, BTMD's ROE is -0.09%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, BTMD is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
BTMD vs ARDT Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ARDT trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ARDT's P/E ratio is 9.43. In terms of profitability, BTMD's ROE is -0.09%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, BTMD is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check ARDT's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
BTMD vs SNDA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while SNDA trades at $34.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas SNDA's P/E ratio is -5.50. In terms of profitability, BTMD's ROE is -0.09%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, BTMD is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check SNDA's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
BTMD vs AMN Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AMN has a market cap of 1.6B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AMN trades at $40.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AMN's P/E ratio is 13.44. In terms of profitability, BTMD's ROE is -0.09%, compared to AMN's ROE of +0.15%. Regarding short-term risk, BTMD is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AMN's competition here
Agilon Health, Inc. (NYSE: AGL)
BTMD vs AGL Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AGL trades at $88.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AGL's P/E ratio is -5.76. In terms of profitability, BTMD's ROE is -0.09%, compared to AGL's ROE of -1.19%. Regarding short-term risk, BTMD is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
BTMD vs HCSG Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while HCSG trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas HCSG's P/E ratio is 16.89. In terms of profitability, BTMD's ROE is -0.09%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, BTMD is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check HCSG's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
BTMD vs PNTG Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while PNTG trades at $40.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas PNTG's P/E ratio is 30.80. In terms of profitability, BTMD's ROE is -0.09%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, BTMD is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
BTMD vs NUTX Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while NUTX trades at $191.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas NUTX's P/E ratio is 7.58. In terms of profitability, BTMD's ROE is -0.09%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, BTMD is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
BTMD vs USPH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while USPH trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas USPH's P/E ratio is 33.08. In terms of profitability, BTMD's ROE is -0.09%, compared to USPH's ROE of -0.01%. Regarding short-term risk, BTMD is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
BTMD vs BKDT Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas BKDT's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, BTMD is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
BTMD vs INNV Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while INNV trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas INNV's P/E ratio is -444.00. In terms of profitability, BTMD's ROE is -0.09%, compared to INNV's ROE of -0.01%. Regarding short-term risk, BTMD is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
BTMD vs TALK Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TALK's P/E ratio is 774.34. In terms of profitability, BTMD's ROE is -0.09%, compared to TALK's ROE of +0.00%. Regarding short-term risk, BTMD is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
BTMD vs EHAB Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas EHAB's P/E ratio is -197.14. In terms of profitability, BTMD's ROE is -0.09%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, BTMD is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
BTMD vs STLN Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while STLN trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas STLN's P/E ratio is -21.13. In terms of profitability, BTMD's ROE is -0.09%, compared to STLN's ROE of +2.10%. Regarding short-term risk, BTMD is more volatile compared to STLN. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
BTMD vs GMRS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, GMRS has a market cap of 540.2M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while GMRS trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas GMRS's P/E ratio is -4.93. In terms of profitability, BTMD's ROE is -0.09%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, BTMD is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
BTMD vs TOI Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TOI's P/E ratio is -14.25. In terms of profitability, BTMD's ROE is -0.09%, compared to TOI's ROE of +2.10%. Regarding short-term risk, BTMD is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
BTMD vs MCTA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas MCTA's P/E ratio is 419.36. In terms of profitability, BTMD's ROE is -0.09%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, BTMD is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
BTMD vs SRTA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, SRTA has a market cap of 401.6M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while SRTA trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas SRTA's P/E ratio is -21.40. In terms of profitability, BTMD's ROE is -0.09%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, BTMD is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
BTMD vs AUNA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AUNA has a market cap of 399.7M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AUNA trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AUNA's P/E ratio is 4.86. In terms of profitability, BTMD's ROE is -0.09%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, BTMD is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
BTMD vs CYH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CYH has a market cap of 389.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CYH trades at $2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CYH's P/E ratio is 3.79. In terms of profitability, BTMD's ROE is -0.09%, compared to CYH's ROE of +0.21%. Regarding short-term risk, BTMD is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check CYH's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
BTMD vs VMD Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, VMD has a market cap of 365.3M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while VMD trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas VMD's P/E ratio is 26.64. In terms of profitability, BTMD's ROE is -0.09%, compared to VMD's ROE of +0.10%. Regarding short-term risk, BTMD is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
BTMD vs CSU Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CSU's P/E ratio is 0.67. In terms of profitability, BTMD's ROE is -0.09%, compared to CSU's ROE of -0.33%. Regarding short-term risk, BTMD is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
BTMD vs JYNT Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, JYNT has a market cap of 103.7M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while JYNT trades at $7.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas JYNT's P/E ratio is 48.87. In terms of profitability, BTMD's ROE is -0.09%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, BTMD is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
BTMD vs FVE Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas FVE's P/E ratio is -5.64. In terms of profitability, BTMD's ROE is -0.09%, compared to FVE's ROE of -0.15%. Regarding short-term risk, BTMD is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
BTMD vs KDLYW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas KDLYW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, BTMD is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check KDLYW's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
BTMD vs AIRS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AIRS has a market cap of 89.8M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AIRS trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AIRS's P/E ratio is -41.50. In terms of profitability, BTMD's ROE is -0.09%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, BTMD is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check AIRS's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
BTMD vs PARK Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, PARK has a market cap of 89.7M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while PARK trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas PARK's P/E ratio is 25.49. In terms of profitability, BTMD's ROE is -0.09%, compared to PARK's ROE of -0.18%. Regarding short-term risk, BTMD is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check PARK's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
BTMD vs EUDA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, EUDA has a market cap of 46.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while EUDA trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas EUDA's P/E ratio is -13.46. In terms of profitability, BTMD's ROE is -0.09%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, BTMD is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check EUDA's competition here
AlerisLife Inc. (NASDAQ: ALR)
BTMD vs ALR Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ALR's P/E ratio is -1.11. In terms of profitability, BTMD's ROE is -0.09%, compared to ALR's ROE of -0.15%. Regarding short-term risk, BTMD is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check ALR's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
BTMD vs CCEL Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CCEL has a market cap of 36.8M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CCEL trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CCEL's P/E ratio is -19.87. In terms of profitability, BTMD's ROE is -0.09%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, BTMD is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
BTMD vs IMAC Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas IMAC's P/E ratio is -2.27. In terms of profitability, BTMD's ROE is -0.09%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, BTMD is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
BTMD vs DCGO Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, DCGO has a market cap of 25.2M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while DCGO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas DCGO's P/E ratio is -0.14. In terms of profitability, BTMD's ROE is -0.09%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, BTMD is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
BTMD vs CANO-WT Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, BTMD is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check CANO-WT's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
BTMD vs PIIIW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, PIIIW has a market cap of 19.1M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas PIIIW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, BTMD is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check PIIIW's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
BTMD vs AIH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AIH's P/E ratio is -2.78. In terms of profitability, BTMD's ROE is -0.09%, compared to AIH's ROE of +1.16%. Regarding short-term risk, BTMD is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
BTMD vs PIII Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, PIII has a market cap of 12.9M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while PIII trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas PIII's P/E ratio is -0.12. In terms of profitability, BTMD's ROE is -0.09%, compared to PIII's ROE of +1.61%. Regarding short-term risk, BTMD is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
BTMD vs CANO Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CANO's P/E ratio is -0.01. In terms of profitability, BTMD's ROE is -0.09%, compared to CANO's ROE of -1.49%. Regarding short-term risk, BTMD is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
BTMD vs FPCG Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas FPCG's P/E ratio is 0.09. In terms of profitability, BTMD's ROE is -0.09%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, BTMD is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
BTMD vs FTRP Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas FTRP's P/E ratio is -1.22. In terms of profitability, BTMD's ROE is -0.09%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, BTMD is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
BTMD vs AMS Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AMS has a market cap of 8.3M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AMS trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AMS's P/E ratio is -4.93. In terms of profitability, BTMD's ROE is -0.09%, compared to AMS's ROE of -0.07%. Regarding short-term risk, BTMD is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
BTMD vs BMGL Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, BMGL has a market cap of 6.4M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while BMGL trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas BMGL's P/E ratio is -0.81. In terms of profitability, BTMD's ROE is -0.09%, compared to BMGL's ROE of -1.64%. Regarding short-term risk, BTMD is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check BMGL's competition here
ModivCare Inc. (NASDAQ: MODV)
BTMD vs MODV Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas MODV's P/E ratio is -0.06. In terms of profitability, BTMD's ROE is -0.09%, compared to MODV's ROE of +0.88%. Regarding short-term risk, BTMD is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
BTMD vs GBNH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas GBNH's P/E ratio is -0.06. In terms of profitability, BTMD's ROE is -0.09%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, BTMD is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
BTMD vs RHE-PA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, BTMD's ROE is -0.09%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, BTMD is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
BTMD vs RHE Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas RHE's P/E ratio is -1.79. In terms of profitability, BTMD's ROE is -0.09%, compared to RHE's ROE of -1.31%. Regarding short-term risk, BTMD is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
BTMD vs TOIIW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, BTMD's ROE is -0.09%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, BTMD is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
BTMD vs AIDX Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AIDX has a market cap of 3.3M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AIDX trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AIDX's P/E ratio is -0.36. In terms of profitability, BTMD's ROE is -0.09%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, BTMD is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check AIDX's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
BTMD vs STLNW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, STLNW has a market cap of 2.8M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while STLNW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas STLNW's P/E ratio is -0.09. In terms of profitability, BTMD's ROE is -0.09%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, BTMD is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
BTMD vs IMACW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas IMACW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, BTMD is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check IMACW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
BTMD vs EUDAW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, EUDAW has a market cap of 971.7K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, BTMD's ROE is -0.09%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, BTMD is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check EUDAW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
BTMD vs EDVA Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, EDVA has a market cap of 871.5K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while EDVA trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas EDVA's P/E ratio is -0.01. In terms of profitability, BTMD's ROE is -0.09%, compared to EDVA's ROE of N/A. Regarding short-term risk, BTMD is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check EDVA's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
BTMD vs CCM Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, CCM has a market cap of 516.7K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while CCM trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas CCM's P/E ratio is -1.20. In terms of profitability, BTMD's ROE is -0.09%, compared to CCM's ROE of +0.05%. Regarding short-term risk, BTMD is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
BTMD vs NIVFW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, NIVFW has a market cap of 35K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas NIVFW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, BTMD is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
BTMD vs TALKW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TALKW's P/E ratio is 0.00. In terms of profitability, BTMD's ROE is -0.09%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, BTMD is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
BTMD vs MNDR Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, MNDR has a market cap of 22.5K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while MNDR trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas MNDR's P/E ratio is -0.06. In terms of profitability, BTMD's ROE is -0.09%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, BTMD is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check MNDR's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
BTMD vs TNONW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TNONW has a market cap of 5.1K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TNONW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TNONW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to TNONW's ROE of N/A. Regarding short-term risk, BTMD is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check TNONW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
BTMD vs NIVF Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, NIVF has a market cap of 4.4K. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while NIVF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas NIVF's P/E ratio is 0.14. In terms of profitability, BTMD's ROE is -0.09%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, BTMD is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check NIVF's competition here
New Frontier Health Corporation (NYSE: NFH)
BTMD vs NFH Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, NFH has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas NFH's P/E ratio is -19.75. In terms of profitability, BTMD's ROE is -0.09%, compared to NFH's ROE of -0.06%. Regarding short-term risk, BTMD is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
BTMD vs SLHGP Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, BTMD's ROE is -0.09%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, BTMD is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check SLHGP's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
BTMD vs ATIP-WT Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, BTMD is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
BTMD vs HNGR Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas HNGR's P/E ratio is 19.71. In terms of profitability, BTMD's ROE is -0.09%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, BTMD is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check HNGR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
BTMD vs TLMDW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TLMDW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, BTMD is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check TLMDW's competition here
Almost Family Inc. (NASDAQ: AFAM)
BTMD vs AFAM Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas AFAM's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, BTMD is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
BTMD vs TLMD Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TLMD's P/E ratio is -1.60. In terms of profitability, BTMD's ROE is -0.09%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, BTMD is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check TLMD's competition here
DocGo Inc. (NASDAQ: DCGOW)
BTMD vs DCGOW Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas DCGOW's P/E ratio is N/A. In terms of profitability, BTMD's ROE is -0.09%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, BTMD is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check DCGOW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
BTMD vs DVCR Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas DVCR's P/E ratio is 28.34. In terms of profitability, BTMD's ROE is -0.09%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, BTMD is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check DVCR's competition here
Kindred Healthcare, Inc. (NYSE: KND)
BTMD vs KND Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, KND has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas KND's P/E ratio is -1.14. In terms of profitability, BTMD's ROE is -0.09%, compared to KND's ROE of -0.53%. Regarding short-term risk, BTMD is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
BTMD vs SLHG Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas SLHG's P/E ratio is -1.48. In terms of profitability, BTMD's ROE is -0.09%, compared to SLHG's ROE of N/A. Regarding short-term risk, BTMD is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for BTMD.Check SLHG's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
BTMD vs TVTY Comparison October 2026
biote Corp. (NASDAQ: BTMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BTMD stands at 47.2M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, BTMD is priced at $1.08 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BTMD currently has a P/E ratio of 9.73, whereas TVTY's P/E ratio is 19.06. In terms of profitability, BTMD's ROE is -0.09%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, BTMD is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for BTMD.Check TVTY's competition here